Pharmaceutical compositions and use thereof
AssigneeSandalwood Biotech Inc.
InventorsBe XIE, Xuefeng REN
Life of this patent
Estimating the term…
Abstract
The present application relates to methods of preventing, treating or managing a respiratory disease and/or a viral infection (e.g., an influenza virus infection and COVID-19) using a pharmaceutical composition produced from one or more preparations of plant parts. Provided herein are the pharmaceutical compositions produced from the one or more preparations. Also provided herein are methods of producing the pharmaceutical composition from the one or more preparations.
Claims55
A method of preventing, treating or managing a respiratory disease and/or a viral infection, comprising administering to a subject in need of such prevention, treatment, or management a pharmaceutical composition produced from preparations comprising:
- (i) a preparation of the fruit of Illicium verum;
- and
- (ii) a preparation of the dried Sclerotium of Poria cocos (Schw.) Wolf, in the weight ratio from 1:1 to 1:10, and
- wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier.
A method of preventing, treating or managing COVID-19, comprising administering to a subject in need of such prevention, treatment, or management a pharmaceutical composition produced from one or more preparations selected from:
- (i) a preparation of the fruit of Illicium verum;
- and
- (ii) a preparation of the dried Sclerotium of Poria cocos (Schw.) Wolf, and
- wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier.
A pharmaceutical composition produced from preparations comprising:
- (i) a preparation of the fruit of Illicium verum;
- and
- (ii) a preparation of the dried Sclerotium of Poria cocos (Schw.) Wolf, in the weight ratio of from 1:1 to 1:10, and
- wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier.
A method of producing a pharmaceutical composition, wherein the method comprises the steps of:
- (a) boiling preparations in water;
- and
- (b) collecting the decoction,
- wherein the preparations comprise:
- (i) a preparation of the fruit of Illicium verum;
- and
- (ii) a preparation of the dried Sclerotium of Poria cocos (Schw.) Wolf, in the weight ratio of from 1:1 to 1:10, and
- wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier.
A method of producing a pharmaceutical composition, wherein the method comprises the steps of:
- (a) boiling preparations in water;
- (b) collecting the decoction;
- (c) filtering the decoction and collecting the filtrate;
- and
- (d) freeze-drying the filtrate to obtain a dry powder;
- wherein the preparations comprise:
- (i) a preparation of the fruit of Illicium verum;
- and
- (ii) a preparation of the dried Sclerotium of Poria cocos (Schw.) Wolf, in the weight ratio of from 1:1 to 1:10, and
- wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier.
A method of preventing, treating or managing an influenza virus infection or COVID-19, comprising administering to a subject in need of such prevention, treatment, or management a pharmaceutical composition produced from one or more preparations comprising:
- (i) the preparation of the fruit of Illicium verum in an amount of 0.3 wt. % to 50 wt. %;
- (ii) the preparation of the dried Sclerotium of Poria cocos (Schw.) Wolf in an amount of 2 wt. % to 90 wt. %;
- (iii) the preparation of the dried fruit skin of Zanthoxylum bungeanum Maxim. in an amount of 0.3 wt. % to 50 wt. %;
- (iv) the preparation of the seed (nut) of Semen Armeniacae Amarum in an amount of 5 wt. % to 50 wt. %;
- (v) the preparation of the dried root and rhizome of Glycyrrhiza uralensis Fisch. in an amount of 5 wt. % to 50 wt. %;
- (vi) the preparation of the dried root of Adenophora stricta Miq. in an amount of 5 wt. % to 50 wt. %;
- and
- (vii) the preparation of the dried root of Scutellaria baicalensis Georgi in an amount of 5 wt. % to 50 wt. %, and
- wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.